Expression and processing of recombinant human galactosylceramidase

Sukehisa Nagano, Takeshi Yamada, Nobue Shinnoh, Hirokazu Furuya, Takayuki Taniwaki, Jun Ichi Kira

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Stable transformants of CHO cells that overexpress human galactosylceramidase (GALC) were established. The GALC within the cell consisted of 50- and 30-kDa proteins. The active GALC secreted into the culture medium in large amounts consisted of the 80-kDa precursor enzyme. We confirmed that the precursor enzyme was taken up by fibroblasts via the mannose-6-phosphate receptor and processed into the 50- and 30-kDa fragments. Fragmentation was inhibited by the lysosomotropic agents chloroquine and NH4Cl, suggesting that it occurs within the lysosome. GALC mutations identified in globoid cell leukodystrophy suppressed fragmentation. Neither the 50- or 30-kDa fragment expressed had GALC activity, indicative that the entire structure is necessary for enzyme activity and that fragments expressed separately cannot associate to form the active enzyme. Copyright (C) 1998 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)53-61
Number of pages9
JournalClinica Chimica Acta
Volume276
Issue number1
DOIs
Publication statusPublished - Aug 10 1998

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Nagano, S., Yamada, T., Shinnoh, N., Furuya, H., Taniwaki, T., & Kira, J. I. (1998). Expression and processing of recombinant human galactosylceramidase. Clinica Chimica Acta, 276(1), 53-61. https://doi.org/10.1016/S0009-8981(98)00095-3